HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Induction of angiotensin-converting enzyme and activation of the renin-angiotensin system contribute to 20-hydroxyeicosatetraenoic acid-mediated endothelial dysfunction.

AbstractOBJECTIVE:
20-hydroxyeicosatetraenoic acid (20-HETE) promotes endothelial dysfunction by uncoupling endothelial NO synthase, stimulating O(2)(-) production, and reducing NO bioavailability. Moreover, 20-HETE-dependent vascular dysfunction and hypertension are associated with upregulation of the renin-angiotensin system This study was undertaken to examine the contribution of renin-angiotensin system to 20-HETE actions in the vascular endothelium.
METHODS AND RESULTS:
In endothelial cells, 20-HETE induced angiotensin-converting enzyme (ACE) mRNA levels and increased ACE protein and activity by 2- to 3-fold; these effects were negated with addition of the 20-HETE antagonist, 20-hydroxyeicosa-6(Z),15(Z)-dienoic acid (20 HEDE). 20-HETE induced ACE expression was protein kinase C independent and epidermal growth factor receptor tyrosine kinase and IκB kinase β dependent. ACE short interfering RNA abolished 20-HETE-mediated inhibition of NO production and stimulation of O(2)(-) generation, whereas angiotensin II type 1 receptor short interfering RNA attenuated these effects by 40%. 20-HETE-stimulated O(2)(-) production was negated by 20-HEDE and was attenuated by lisinopril and losartan. Importantly, 20-HETE-mediated impairment of acetylcholine-induced relaxation in rat renal interlobar arteries was also attenuated by lisinopril and losartan.
CONCLUSIONS:
These results indicate that ACE and angiotensin II type 1 receptor activation contribute to 20-HETE-mediated endothelial cell and vascular dysfunction and further enforce the notion that excessive production of 20-HETE within the vasculature leads to hypertension via mechanisms that include the induction of endothelial ACE, thus, perpetuating an increase in vascular angiotensin which, together with 20-HETE, promotes vascular dysfunction.
AuthorsJennifer Cheng, Victor Garcia, Yan Ding, Cheng-Chia Wu, Krutanjali Thakar, John R Falck, Errabelli Ramu, Michal Laniado Schwartzman
JournalArteriosclerosis, thrombosis, and vascular biology (Arterioscler Thromb Vasc Biol) Vol. 32 Issue 8 Pg. 1917-24 (Aug 2012) ISSN: 1524-4636 [Electronic] United States
PMID22723444 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Hydroxyeicosatetraenoic Acids
  • Superoxides
  • Angiotensin II
  • 20-hydroxy-5,8,11,14-eicosatetraenoic acid
  • Protein-Tyrosine Kinases
  • I-kappa B Kinase
  • Peptidyl-Dipeptidase A
  • Acetylcholine
Topics
  • Acetylcholine (pharmacology)
  • Angiotensin II (biosynthesis)
  • Cells, Cultured
  • Endothelial Cells (drug effects, metabolism)
  • Enzyme Induction (drug effects)
  • Humans
  • Hydroxyeicosatetraenoic Acids (pharmacology)
  • I-kappa B Kinase (physiology)
  • Peptidyl-Dipeptidase A (biosynthesis)
  • Protein-Tyrosine Kinases (physiology)
  • Renin-Angiotensin System (drug effects, physiology)
  • Superoxides (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: